JonathanDavidPowellMD

Associate Professor, Oncology, Johns Hopkins University School of Medicine

Are you Dr. Powell?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 78 invites waiting!
Read the latest clinical news, personalized to your specialty.

Dr. Jonathan Powell, MD is an oncologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland and Massachusetts. He is an Associate Professor at Johns Hopkins University School of Medicine.

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1995 - 1998
Johns Hopkins UniversityResidency, Internal Medicine, 1992 - 1995
Emory University School of MedicineClass of 1992

PubMed

44 citations
Inhibition of the Adenosine Pathway to Potentiate Cancer Immunotherapy: Potential for Combinatorial Approaches
Elizabeth A. Thompson, Jonathan D. Powell
Annual Review of Medicine. 2021-01-27
629 citations
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert Leone, Liang Zhao, Judson Englert, Im Meng Sun, Min Hee Oh
Science. 2019-11-22
522 citations
Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR2
Kara A. Scheibner, Michael A. Lutz, Sada Boodoo, Matthew J. Fenton, Jonathan D. Powell
Journal of Immunology. 2006-07-15

GSK-Backed Biotech Gets $50M Upfront in Autoimmune Disease Deal with LillyMarch 31st, 2020
Another Immunometabolism Deal? Johns Hopkins Spinout Dracen Lands $36M Investment from DeerfieldMarch 22nd, 2018
Corvus Pharmaceuticals to Host R&D Day Highlighting the Role of the Adenosine Pathway in Immuno-OncologyMarch 9th, 2017
Join now to see all